Senior Director, Global Value & Access Pipeline Strategy – HIV Treatment jobs in United States
cer-icon
Apply on Employer Site
company-logo

Gilead Sciences · 1 week ago

Senior Director, Global Value & Access Pipeline Strategy – HIV Treatment

Gilead Sciences is a research-based biopharmaceutical company focused on developing innovative therapies for life-threatening illnesses. The Senior Director, Global Value & Access Pipeline Strategy will be responsible for developing early Global Value & Access strategies for the HIV treatment pipeline, collaborating with various teams to optimize access and reimbursement strategies.

BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Responsible for leading the development of the Global V&A Strategy, payer value story and stakeholder engagement plans for the HIV Treatment pipeline to optimise access, reimbursement and uptake in core markets (US, EU4, UK, Canada, China & Japan)
Representing core markets’ V&A perspective with comprehensive input to G.Ecosystem teams, ensuring global payer/HTA perspectives and evidence requirements are reflected
Cultivate close partnership with program strategy leaders (PSLs), clinical development leaders (GDLs) and commercialization team leaders (CTLs) to provide guidance and input to G.Ecosystem deliverables (e.g. commercial assessments, clinical development plans, integrated evidence plans)
Collaborate with Global HEOR and Global Pricing & Analytics to bring relevant V&A insights and expertise to G.Ecosystem teams and governance decisions
Collaborate with cross-functional partners/leaders in Global Strategic Marketing (GSM), Global Decision Science & Insights (GDSI), Global Medical Affairs (GMA), Government Affairs & Policy, Public Affairs and Regulatory Affairs to drive integrated pipeline commercialization strategies
Lead payer, pricing & access and competitive research to understand value perception, landscape, evolving trends, value drivers and innovative pricing and access strategies

Qualification

Global Value & Access StrategyMarket Access ExperiencePayer Environment KnowledgeBiotech/Pharmaceutical ExperienceHIV Disease Area KnowledgeStakeholder EngagementOperational ExcellenceStrategic ThinkingCommunication SkillsFacilitation Skills

Required

14+ Years with BS/BA OR
12+ Years with MS/MA or MBA

Preferred

Relevant experience in the biotech or pharmaceutical industry in market access-related activities
Advanced degree in life sciences, health policy or medical degree
Experience in global or regional (above-country) market access, launch planning and execution is required – US managed care/market access experience is an advantage
HIV disease area experience and market knowledge is preferred but not essential
Strong understanding of payer environment, including HTA, pricing and reimbursement, contracting and negotiation, and policy development
Demonstrated ability to lead and influence across functions and levels in a matrix environment: skilled facilitator, communicator and strategic thinker
Ability to engage and manage multiple stakeholders to achieve the objective
Strong communicator; Curious with learning agility; Operationally excellent

Benefits

Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans

Company

Gilead Sciences

company-logo
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

H1B Sponsorship

Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)

Funding

Current Stage
Public Company
Total Funding
$4.41B
Key Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B

Leadership Team

leader-logo
Keeley Wettan
Senior Vice President, Legal
linkedin
leader-logo
Patrick Loerch
Senior Vice President, Clinical Data Science
linkedin
Company data provided by crunchbase